Articles by Moheb Nasr - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Moheb Nasr

Moheb Nasr


Moheb Nasr is director at the Office of New Drug Quality Assessment in FDA's Center for Drug Evaluation and Research, 10903 New Hampshire Ave., Bldg. 21, Rm. 2630, Silver Spring, MD 20993-0002.

Articles
The Role of Analytical Science in Implementing Quality by Design
March 2, 2013

The authors present topics discussed and conclusions that resulted from the PDA QbD workshop.

Inside ICH: ICH Meets in Japan to Finalize Key Documents
January 2, 2011

Expert and implementation working groups harmonize more guidelines and move Q11 forward.

Inside ICH: Quality Trio Takes Final Shape
June 2, 2009

FDA leaders explain the purpose and plan for ICH's three quality guidelines.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here